サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：アンギオ（血管造影）スイートの世界市場-2022-2029
市場調査レポート
商品コード
1129252

アンギオ（血管造影）スイートの世界市場-2022-2029

Global Angio Suites Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円
アンギオ（血管造影）スイートの世界市場-2022-2029
出版日: 2022年09月29日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

インターベンショナルオンコロジーにおける精密治療用CTシステムの技術的進歩が市場成長を牽引すると予想されます。

インターベンショナル・ラジオロジーは、標準的な血管造影画像と断面画像を組み合わせた複合血管造影CT（アンギオCT）システムから大きなメリットを得ています。フラットパネル血管造影システムのコーンビームCT（CBCT）技術は、インターベンショナル手術の際に補助的な断面撮影ツールとして長年使用されてきましたが、アンジオCTシステム固有の利点である優れた軟組織イメージングとコントラスト分解能、および操作の容易さから、インターベンショナル腫瘍学治療への適用に再び関心が集まっています。Angio-CTシステムは、ワークフローの改善により価格と使いやすさが向上したため、CBCTを搭載したスタンドアロンのフラットパネル血管造影システムに代わる競争力のあるシステムとして台頭してきました。さらに、CTスキャナーによる断面画像と血管造影装置による透視画像を組み合わせることで、腫瘍学的介入をより正確に計画し、複数の治療法を一箇所で組み合わせ、術中治療反応を追跡し、合併症を最小限に抑え、治療成績を向上させることができます。したがって、上記の記述から、予測期間中に市場が牽引されることが予想されます。

制約事項

アンギオ（血管造影）スイートの設置に伴う高いコスト、アンギオ（血管造影）スイートの使用に習熟した人材の不足、再生画像診断機器の使用増加、大きな放射線被曝リスクなどが、予測期間中に市場が阻害される要因の1つです。

産業分析

アンギオ（血管造影）スイート市場は、ポーターの5つの力、サプライチェーン分析、償還シナリオ、製品イノベーション、価格分析など、様々な業界要因に基づいた市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19のパンデミックは、ヘルスケアシステムと市場に中程度の影響を与えています。心臓病やその他の慢性疾患の症例は、コロナウイルスが活動している間、パンデミック中に増加しました。アンギオ（血管造影）スイートは、人間の血管、特に動脈の内部を可視化し、正確かつ効果的な診断を行うための最先端の装置であるため、その需要は急増しました。COVID-19の急増に伴い、心臓病の患者が急増し、最新のアンギオ（血管造影）スイートの必要性が高まったのです。米国疾病管理予防センターは、安定した冠動脈疾患に対する冠動脈造影や経皮的冠動脈インターベンションなどの選択的心臓手術を延期し、個人防護具や病院のベッドなどの資源を節約してCOVID-19患者のケアにあてることを提案しました。COVIDの流行の初期段階において、米国の心臓カテーテル検査室におけるSTEMIの活性化は38％減少し、スペインで見られた40％の減少に匹敵すると予測されています。

さらに、パンデミックはサプライチェーンとプロセスに支障をきたします。多くの企業は、製品の入手可能性を確保し、サプライチェーンを保護するために、他の地域へと変化していきます。したがって、上記の文から、市場は影響を受け、それは経済活動の再開と迅速にトラクションを得ることが期待されるようになっています。

世界のアンギオ（血管造影）スイート市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場影響要因
    • 促進要因
      • インターベンショナルオンコロジーにおける精密治療用CTシステムの技術的進歩が市場成長を促進すると予想されます。
    • 抑制要因
      • アンギオ（血管造影）スイートの設置に伴う高コストが市場成長を阻害すると予想されます。
    • 市場機会
    • 影響分析

第5章 産業分析

  • サプライチェーン分析
  • 価格設定分析
  • アンメットニーズ分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、あるいは将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 タイプ別

  • シングルプレーン
  • 複葉機

第8章 装置別

  • X線発生装置
  • Cアーム
  • X線検出器
  • 手術台
  • その他

第9章 アプリケーション別

  • 血管形成術
  • ステント治療
  • 閉塞性バイパス術
  • 血管内治療
  • 椎弓形成術
  • 骨髄造影剤
  • 動脈・静脈奇形手術
  • 冠動脈造影
  • その他

第10章 エンドユーザー別

  • 病院
  • 診断センター
  • 心臓血管カテーテル検査室
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第13章 企業プロファイル

  • Siemens Healthcare GmbH
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Carestream Health
  • Canon Medical Systems Corporation
  • Shimadzu Corp
  • 3D Systems
  • IMRIS

第14章 アンギオ（血管造影）スイートの世界市場-DataM

目次
Product Code: DMMI5803

Market Overview

The Angio Suites Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 5% during the forecast period (2022-2029).

Angio suites are well-resourced, multipurpose areas used to carry out interventional vascular procedures. These facilities carry out several medical treatments, including minimally invasive endovascular surgery, ischemic stroke treatment, myelograms, aortic dissection, ruptured aneurysms, diagnostic imaging techniques, and medical imaging practices. The Angio suites' adaptability is a real asset because it allows for the execution of numerous medical operations. Angio suites offer a one-stop solution to patients, reducing the real trauma of the surgery by eliminating the need for patients to transition between various operating rooms.

Market Dynamics

Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.

Interventional radiology greatly benefits from combined angiography-CT (angio-CT) systems, which combine standard angiographic imaging with cross-sectional imaging. Although flat-panel angiography systems' cone-beam CT (CBCT) technology has long been used as an adjunct cross-sectional imaging tool during interventional procedures, the inherent benefits of angio-CT systems' superior soft-tissue imaging and contrast resolution, as well as their ease of operation, have reignited interest in their application to interventional oncology procedures. Angio-CT systems have emerged as a competitive alternative to standalone flat-panel angiographic systems with CBCT due to gains in pricing and usability brought on by improved workflow. Additionally, cross-sectional imaging from the CT scanner and fluoroscopic imaging from the angiography system are combined to more precisely plan oncologic interventions, combine multiple therapies in one location, and track intraprocedural treatment responses, minimizing complications and enhancing therapeutic outcomes. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High costs associated with arranging angio suites, lacking skilled personnel who are proficient at using angio suites and increasing usage of reconditioned diagnostic imaging equipment, and significant radiation exposure risk are some of the factors the market is expected to hamper in the forecast period.

Industry Analysis

The angio suites market provides in-depth analysis of the market based on various industry factors such as porter's five forces, supply chain analysis, reimbursement scenario, product innovation, pricing analysis, etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. Heart disease and other chronic disease cases increased during the pandemic while the coronavirus was active. Because angio suites are the cutting-edge interventions used for precise and effective diagnosis that aid in visualizing the interior of human blood vessels, particularly the arteries, demand for them has skyrocketed. The abrupt and uncontrolled rise in COVID-19 cases led to a surge in patients with heart disease, raising the need for modern angio suites. The Centers for Disease Control and Prevention suggested postponing elective cardiac procedures, such as coronary angiography and percutaneous coronary intervention for stable coronary artery disease, to conserve resources, including personal protective equipment and hospital beds to care for COVID-19 patients. During the early stages of the COVID epidemic, it is predicted that STEMI activations in cardiac catheterization laboratories in the United States decreased by 38%, matching the 40% reduction seen in Spain.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Angioplasty segment is expected to hold the largest market share in angio suites market

The angioplasty segment is expected to dominate in 2021. The segment is beneficial because angioplasty is a procedure used to open coronary arteries that have become blocked due to coronary artery disease. Additionally, angioplasty has fewer scars, lessens post-operative side effects, a greater success rate, low invasion, and quick recovery. Additionally, as the burden of coronary heart disease rises, the demand for angioplasty increases since it can be used to enlarge blocked or restricted coronary arteries, keeping the patient safe. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global angio suites market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of cardiovascular diseases, rising investments in research & development, increasing high-quality medical facilities, including hospitals and laboratories, high level of awareness of healing difficulties and the availability of effective treatments and product launches and acquisitions by the key market players are some of the factors the market is expected to boost in the forecast period. For instance, In the United States, heart disease is the leading cause of death for both sexes and members of most racial and ethnic groups. Cardiovascular disease claims one life in the United States every 36 seconds. One in four deaths in the US is caused by heart disease, which affects about 659,000 people annually. Moreover, according to the American Heart Association, in 2019, at least 48 percent of adults in the United States suffer from cardiovascular disease.

Additionally, a subsidiary of renowned Massachusetts-based firm General Electric, GE Healthcare, announced the successful acquisition of Boston, Massachusetts-based imaging company "BK Medical" on December 21, 2021. The deal has been completed with a $1.45 billion payment from GE. Furthermore, the deal has helped GE Healthcare's ultrasound division grow. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the angio suites market are Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Carestream Health, Canon Medical Systems Corporation, Shimadzu Corp, 3D Systems, IMRIS.

3D Systems:

Overview:

A 3D printing service is provided by 3D Systems, a business with its main office in Rock Hill, South Carolina, which also designs, produces, and sells 3D printers, 3D printing supplies, and 3D scanners. The business produces master patterns for tooling, functional prototypes, production parts for direct digital manufacturing, and concept models for new product ideas. Input from computer-aided design and manufacturing software, 3D scanning, and 3D sculpting tools is used to produce real products utilizing proprietary techniques. Numerous industries, including aerospace, automotive, healthcare, dental, entertainment, and the creation of durable goods, employ the technologies and services provided by 3D Systems. The business provides a selection of 3D printers suitable for professional and industrial use, software, materials, and an online service for producing quick parts.

Product Portfolio:

Simulator-Angio-Mentor: ANGIO Mentor simulators provide multi-specialty hands-on practice of endovascular interventions in an extensive simulated clinical environment of a cath lab, interventional suite or a hybrid operating room. It provides a complete individual and team training solutions to learners of all levels.

The global angio suites market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancement in the CT Systems for Precision therapy in interventional oncology is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. High costs associated with arranging angio suites is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type Segment
  • 7.2. Single plane*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Biplane

8. By Equipment

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 8.1.2. Market Attractiveness Index, By Equipment Segment
  • 8.2. X-Ray Generator*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. C-Arm
  • 8.4. X-Ray Detector
  • 8.5. Operating Table
  • 8.6. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application Segment
  • 9.2. Angioplasty*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Therapeutic Stenting
  • 9.4. Obstruction Bypasses
  • 9.5. Intravascular Therapy
  • 9.6. Vertebroplasty
  • 9.7. Myelograms
  • 9.8. Arterial venous malformations surgery
  • 9.9. Coronary angiograms
  • 9.10. Others

10. By End user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.1.2. Market Attractiveness Index, By Distribution Channel Segment
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Centers
  • 10.4. Cardiovascular catheterization laboratories
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Equipment
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Siemens Healthcare GmbH*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Koninklijke Philips N.V.
  • 13.3. GE Healthcare
  • 13.4. Carestream Health
  • 13.5. Canon Medical Systems Corporation
  • 13.6. Shimadzu Corp
  • 13.7. 3D Systems
  • 13.8. IMRIS

LIST NOT EXHAUSTIVE

14. Global Angio Suites Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Applications
  • 14.3. Contact Us